{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:59:23Z","timestamp":1793735963704,"version":"4.6.1"},"reference-count":47,"publisher":"Media Sphere Publishing House","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["S.S. Korsakov J. Neuro. Psych."],"published-print":{"date-parts":[[2024,4,23]]},"abstract":"<jats:p>The review presents the main physiological functions of thrombin. The procoagulant and anticoagulant activities of the key serine protease are discussed in both physiological and pathological conditions of hemostasis. The involvement of thrombin in atherogenesis, as well as its role as a mediator of vascular dysfunction and inflammation in both the peripheral and central nervous system, is highlighted. A pronounced imbalance between the pro- and anticoagulant systems leads to an increase in thrombin formation and creates conditions for the development of thrombosis. Tests that allow direct or indirect assessment of thrombin\u2019s functional activity are presented. The potential applications of direct thrombin inhibitors and direct blockers of thrombin PAR receptors in vascular neurology are also considered.<\/jats:p>","DOI":"10.17116\/jnevro202412403242","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T14:26:34Z","timestamp":1711031194000},"page":"42","source":"Crossref","is-referenced-by-count":6,"special_numbering":"Vyp. 2","title":["The multidirectional effects of thrombin and the possibility of their control in neurology"],"prefix":"10.17116","volume":"124","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3146-0822","authenticated-orcid":false,"given":"M.D.","family":"Chan","sequence":"first","affiliation":[{"name":"Pirogov Russian National Research Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4618-922X","authenticated-orcid":false,"given":"A.N.","family":"Yasamanova","sequence":"additional","affiliation":[{"name":"Pirogov Russian National Research Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8985-8227","authenticated-orcid":false,"given":"G.G.","family":"Avakian","sequence":"additional","affiliation":[{"name":"Pirogov Russian National Research Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5221-0478","authenticated-orcid":false,"given":"A.A.","family":"Nikonova","sequence":"additional","affiliation":[{"name":"Pirogov Russian National Research Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6747-3476","authenticated-orcid":false,"given":"P.R.","family":"Kamchatnov","sequence":"additional","affiliation":[{"name":"Pirogov Russian National Research Medical University","place":["Moscow, Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6743","reference":[{"key":"key-10.17116\/jnevro202412403242-1","unstructured":"Sturov VG, Sergeeva IG, Tulupov AA. Cerebrovascular diseases and pathology of hemostasis: textbook; Novosib. state univ. Novosibirsk: RIC NSU; 2015. (In Russ.)"},{"key":"key-10.17116\/jnevro202412403242-2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvp066"},{"key":"key-10.17116\/jnevro202412403242-3","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.608391"},{"key":"key-10.17116\/jnevro202412403242-4","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12045"},{"key":"key-10.17116\/jnevro202412403242-5","doi-asserted-by":"publisher","DOI":"10.1097\/MBC.0000000000001130"},{"key":"key-10.17116\/jnevro202412403242-6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-11-882993"},{"key":"key-10.17116\/jnevro202412403242-7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-07-368811"},{"key":"key-10.17116\/jnevro202412403242-8","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2020.12.200508"},{"key":"key-10.17116\/jnevro202412403242-9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01484.x"},{"key":"key-10.17116\/jnevro202412403242-10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2007.02482.x"},{"key":"key-10.17116\/jnevro202412403242-11","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-10-0811"},{"key":"key-10.17116\/jnevro202412403242-12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1265293"},{"key":"key-10.17116\/jnevro202412403242-13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M408961200"},{"key":"key-10.17116\/jnevro202412403242-14","doi-asserted-by":"publisher","DOI":"10.2741\/1977"},{"key":"key-10.17116\/jnevro202412403242-15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0711055105"},{"key":"key-10.17116\/jnevro202412403242-16","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-813456-6.00023-0"},{"key":"key-10.17116\/jnevro202412403242-17","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2003.09.014"},{"key":"key-10.17116\/jnevro202412403242-18","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8835"},{"key":"key-10.17116\/jnevro202412403242-19","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.003"},{"key":"key-10.17116\/jnevro202412403242-20","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.27771"},{"key":"key-10.17116\/jnevro202412403242-21","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4952131"},{"key":"key-10.17116\/jnevro202412403242-22","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.03.006"},{"key":"key-10.17116\/jnevro202412403242-23","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00762"},{"key":"key-10.17116\/jnevro202412403242-24","doi-asserted-by":"publisher","DOI":"10.1160\/TH10-11-0711"},{"key":"key-10.17116\/jnevro202412403242-25","doi-asserted-by":"publisher","DOI":"10.21518\/2307-1109-2013-1-66-72"},{"key":"key-10.17116\/jnevro202412403242-26","doi-asserted-by":"publisher","DOI":"10.31857\/S0233475522010042"},{"key":"key-10.17116\/jnevro202412403242-27","doi-asserted-by":"publisher","DOI":"10.1159\/000071636"},{"key":"key-10.17116\/jnevro202412403242-28","doi-asserted-by":"publisher","DOI":"10.18087\/cardio.2022.3.n1968"},{"key":"key-10.17116\/jnevro202412403242-29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2011.03916.x"},{"key":"key-10.17116\/jnevro202412403242-30","doi-asserted-by":"publisher","DOI":"10.1160\/TH13-04-0277"},{"key":"key-10.17116\/jnevro202412403242-31","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht134"},{"key":"key-10.17116\/jnevro202412403242-32","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30356-9"},{"key":"key-10.17116\/jnevro202412403242-33","unstructured":"Tkacheva ON, Akasheva DU. Dabigatran in the prevention of stroke in nonvalvular atrial fibrillation: Complex clinical situations and real clinical practice. Terapevticheskii Arkhiv. 2014;86(4):103-107. (In Russ.)"},{"key":"key-10.17116\/jnevro202412403242-34","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113697"},{"key":"key-10.17116\/jnevro202412403242-35","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.107.019083"},{"key":"key-10.17116\/jnevro202412403242-36","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-06-0382"},{"key":"key-10.17116\/jnevro202412403242-37","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612"},{"key":"key-10.17116\/jnevro202412403242-38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1813959"},{"key":"key-10.17116\/jnevro202412403242-39","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-20-0563"},{"key":"key-10.17116\/jnevro202412403242-40","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.027569"},{"key":"key-10.17116\/jnevro202412403242-41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1502000"},{"key":"key-10.17116\/jnevro202412403242-42","unstructured":"Ushkalova E.A. Vorapaxar is the first representative of a new class of antiplatelet agents. Pharmateka. 2014;9(282):76-80. (In Russ.)"},{"key":"key-10.17116\/jnevro202412403242-43","unstructured":"U.S. Food and Drug Administration. Drug Trials Snapshot: Zontivity (vorapaxar) [press release]. September 5, 2017.  https:\/\/www.fda.gov\/drugs\/drug-approvals-and-databases\/drug-trials-snapshot-zontivity-vorapaxar"},{"key":"key-10.17116\/jnevro202412403242-44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200933"},{"key":"key-10.17116\/jnevro202412403242-45","doi-asserted-by":"publisher","DOI":"10.1177\/1747493016632253"},{"key":"key-10.17116\/jnevro202412403242-46","unstructured":"Kolodzeyskaya MV, Grishchuk VI, Chernyshenko TM, et al. Recombinant anticoagulant form of human \u03b1-thrombin. Biotechnol acta. 2009;3:12-19. (In Russ.)"},{"key":"key-10.17116\/jnevro202412403242-47","doi-asserted-by":"crossref","unstructured":"Receivd 20.12.2023","DOI":"10.1055\/a-1996-7269"}],"container-title":["S.S. Korsakov Journal of Neurology and Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T05:43:15Z","timestamp":1745386995000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova-2\/2024\/3-2\/1199772982024032042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3,21]]}},"alternative-id":["10.17116\/jnevro202412403242"],"URL":"https:\/\/doi.org\/10.17116\/jnevro202412403242","relation":{},"ISSN":["1997-7298"],"issn-type":[{"value":"1997-7298","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}